Season 5 Episode 17

I Will Follow You Into the Dark

I Will Follow You Into the Dark is curated around five confirmed medical threads: Patient X/Izzie's metastatic melanoma, Tricia Shelley's CDH1 mutation with stage I gastric cancer, Megan Shelley's CDH1 preventive gastrectomy with negative pathology, Michael Shelley's CDH1 refusal, and Beth Dearborn's ARVC seizure mimic.

Air date: Mar 12, 2009

Explore 5 medical cases

diagnostic realism

3.7/5

overall

3.6/5

procedure realism

3.5/5

workflow realism

3.4/5

Medical Cases in This Episode

These are the patient stories worth unpacking. Open any case for the real-world medicine, what the episode shows, what it leaves out, and source-backed context.

5 cases identified

Case 1

Patient X/Izzie Stevens: Metastatic Melanoma With Brain, Liver, and Skin Metastases

Patient X's hallucinations are traced to metastatic melanoma with brain, liver, and skin spread.

Episode shows: Izzie gives the interns Patient X's scans and history while hiding that she is the patient. They initially think the case may be anxiety, but Izzie says the hallucinations are visual, auditory, and tactile. Lexie pushes for MRI with contrast and lymph node bio...
Clinical takeaway: The case is relevant because neurologic or psychiatric-appearing symptoms can reflect brain metastasis, and a skin cancer diagnosis can become systemic.

Accuracy 3.6/5patient-x-izzie-stevens-metastatic-melanoma-brain-liver-skin-metastases

Case 2

Tricia Shelley: CDH1 Mutation, Stage I Gastric Cancer, and Prophylactic Gastrectomy

Tricia's preventive gastrectomy finds stage I gastric cancer and becomes curative in the episode.

Episode shows: Tricia and her siblings test positive for CDH1 after many family deaths from gastric cancer. She pushes the family pact for prophylactic gastrectomy. During surgery, the team finds stage I cancer and tells the siblings the operation saved her life.
Clinical takeaway: The case is relevant because CDH1-related hereditary diffuse gastric cancer can lead to preventive gastrectomy decisions before symptoms.

Accuracy 3.6/5tricia-shelley-cdh1-stage-one-gastric-cancer-prophylactic-gastrectomy

Case 3

Megan Shelley: CDH1 Mutation and Prophylactic Gastrectomy With No Cancer Found

Megan chooses preventive gastrectomy after Tricia's cancer is found, but her pathology is negative.

Episode shows: Megan is CDH1-positive and initially hesitates when she learns what gastrectomy will do to her life. After Tricia's stage I cancer is found, Megan proceeds. Her path report shows no cancer in her stomach.
Clinical takeaway: The case is relevant because preventive surgery can be reasonable even when pathology later shows no cancer, but the choice should be informed and personal.

Accuracy 3.5/5megan-shelley-cdh1-mutation-prophylactic-gastrectomy-no-cancer

Case 4

Michael Shelley: CDH1 Mutation and Refusal of Prophylactic Gastrectomy

Michael's case is inherited cancer risk plus informed refusal under family pressure.

Episode shows: Michael is CDH1-positive but backs out after learning the consequences of gastrectomy. Tricia pressures him after her cancer is found, but Michael says he is old enough to decide for himself and wants to be left alone.
Clinical takeaway: The case is relevant because risk-reducing surgery still requires consent, and family fear can become coercive.

Accuracy 3.4/5michael-shelley-cdh1-mutation-declines-prophylactic-gastrectomy

Case 5

Beth Dearborn: ARVC Misdiagnosed as Seizures With Ventricular Fibrillation and Device Therapy

Beth's apparent seizures are caused by dangerous heart rhythm events from ARVC.

Episode shows: Beth arrives after seizing during marching band and has been treated as having epilepsy for six years. Alex notices her heart goes into V-fib before she seizes. An EP study suggests ARVC, and she receives a pacemaker/device and cardiology follow-up.
Clinical takeaway: The case is relevant because cardiac arrhythmias can cause convulsive syncope and be mistaken for epilepsy.

Accuracy 3.7/5beth-dearborn-arvc-misdiagnosed-seizures-vfib-and-device-therapy

Episode Summary

I Will Follow You Into the Dark follows three major diagnostic themes across five case cards. Patient X is diagnosed with metastatic melanoma involving brain, liver, and skin. The Shelley siblings each face CDH1 hereditary diffuse gastric cancer risk differently: Tricia's gastrectomy finds stage I cancer, Megan proceeds with preventive surgery and has no cancer, and Michael refuses surgery for now. Beth Dearborn's long-standing seizure diagnosis is reframed as ARVC with ventricular arrhythmia causing convulsive events.

Differential Diagnosis and Testing Logic

Patient X requires not dismissing hallucinations as anxiety when imaging/biopsy can reveal brain metastasis. The Shelley siblings show three distinct CDH1 outcomes: active early cancer, carrier status with negative pathology, and carrier status with refusal. Beth's case requires recognizing seizure mimic: arrhythmia can cause cerebral hypoxia and convulsions, so telemetry and EP testing can be decisive.

Medical Accuracy Review

The episode's best medical work is diagnostic reframing: Patient X is not anxiety, Megan is not cancer-positive, Michael is not obligated to surgery, and Beth is not simply epileptic. The main compressions are oncology staging, modern melanoma treatment, genetic counseling, gastrectomy recovery, ARVC genetic/family screening, and device-selection detail.

Sources and Further Reading

Episode evidence: iDRief catalog page, Grey's Anatomy Universe episode notes, and available transcript context. Medical context: MedlinePlus melanoma, ARVC, and pacemaker/defibrillator resources; NCI melanoma and hereditary diffuse gastric cancer resources; NCI PDQ on HDGC; CDH1 guideline literature; NCBI ARVC reference.

Educational Disclaimer

This page is for general education and TV medical analysis only. It is not medical advice, diagnosis, or treatment guidance. iDRief is independent and is not affiliated with any network, studio, streaming service, hospital, medical school, or rights holder.